Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AudioCodes Reports Third Quarter 2024 Results
-
Record Breaking Participation at Largest Taiwan Creative Content Festival Yet Drives Investment Potential
-
Zilliant Establishes European Customer Advisory Board to Enhance Regional Market Insights
-
Zilliant Enables Sellers to Close Deals Faster with Automated Customer-Specific Pricing in CPQ
-
Altera Infrastructure announces divestment of Altera Shuttle Tankers L.L.C.
-
Vaisala updates its strategy and long-term financial targets
-
Aktia Bank Plc’s directed share issue as a part of the long-term share savings plan
-
OSB GROUP PLC – Q3 Trading Update
-
The DÉKUPLE Group expands internationally with a majority stake in GUD.berlin
-
Transaction in Own Shares
-
The detailed spatial plan of the next stage of Kodulahe has been adopted
-
Fingerprint Cards signs global distribution agreement with Future Electronics
-
Akastor ASA: Akastor purchases ownership interests in AKOFS Offshore from Mitsui
-
Sinch AB: Interim report, January - September 2024
-
Ex dividend NOK 0.50 today
-
Skanska: Interim report, third quarter 2024
-
MSD Employment Law Is Giving Back to Community With Scholarships to Law School Students
-
GTI Initiates Global Recruitment for Intelligent RAN, Ubiquitous AI Project of 5G-A×AI Development Program
-
More than 18 billion worth of agreements signed on opening day of Biban 2024
-
Californians Against Retail And Residential Theft Celebrate the Passage of Proposition 36
-
Multiconsult third quarter result 2024 - very strong quarter
-
Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024
-
BRSK (BeaverStock) Is Now Available for Trading on LBank Exchange
-
Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024
-
Pandora delivers 11% organic growth in Q3
-
Report for the nine months ended 30 September 2024
-
Sampo plc’s share buybacks 5 November 2024
-
Cihan Media: Industry Leaders Champion Practical AI Education through the Revolutionary TABS-D Framework
-
"The Senior Care Influencer" Lance A. Slatton becomes Official Brand Ambassador for Echobox Memory Vault
-
Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
-
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report
-
Andrew Zhou’s 3D U-Net Model Advances Brain Metastasis Segmentation and Streamlines MRI-to-3D Surgical Planning on HoloLens, Featured in XYZ Media's “Next Generation of Innovators”
-
Pentabase to Participate as Official Community Partner for Web3 Oscar, Championing Blockchain for Social Impact
-
Andrew Zhou’s 3D U-Net Model Advances Brain Metastasis Segmentation and Streamlines MRI-to-3D Surgical Planning on HoloLens, Featured in XYZ Media's “Next Generation of Innovators”
-
Arkema: Third-Quarter 2024 Results
-
CTP N.V. Q3-2024 Results
-
Aktia Bank Plc’s Interim Report January–September 2024: Stable quarterly result and positive trend in asset management
-
Credit Agricole Sa: Third quarter and first nine months 2024 results - VERY STRONG QUARTER, 2024 INCOME TARGET CONFIRMED
-
Start of Day Message
-
IBA signs contract with SteriLab for E-beam sterilization solution in the Dominican Republic
-
2024 11 05 - Lexibook - CP mise à disposition de la note d'information et du document autres informations
-
2024 11 05 - Doodle - CP mise à disposition de la note d information et du document autres informations
-
SIKA CLOSES ACQUISITION OF CHEMA – A HIGH-PERFORMING MORTAR COMPANY IN PERU
-
Solvay third quarter 2024 results
-
INTERIM REPORT OF MARIMEKKO, 1 Jan – 30 Sept 2024: Marimekko’s net sales in Q3 nearly at the record level of the comparison period despite the timing of non-recurring promotional deliveries, opera
-
Ultimovacs ASA Reports Third Quarter 2024 Financial Results and Provides General Business Update
-
Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
-
Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis
-
The Melrose Ventures Group Makes Take-Over Bid on Hank Payments Corp
-
Change in Marimekko’s financial reporting dates in 2025

